Clinical Trials
3 trialsNCT07625644 2026-06-04
Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer
SystImmune Inc.
Phase 3 Not yet recruiting
NCT02688036 2026-05-29
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Completed
NCT03910660 2026-05-15
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
Phase 1/2 Completed